HN Logo
Prior Authorization Protocol
PRESTALIAR (perindopril/amlodipine)
NATL
Coverage of drugs is first determined by the member’s pharmacy or medical benefit. Please consult with or refer to the Evidence of Coverage document.
  1. FDA Approved Indications:
    • For the treatment of hypertension to lower blood pressure in patients not adequately controlled with monotherapy or as initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals
  2. Health Net Approved Indications and Usage Guidelines:
    • Medical justification must be provided why individual generic components of perindopril and amlodipine cannot be used
  3. Coverage is Not Authorized For:
    • Non-FDA approved indications, which are not listed in the Health Net Approved Indications and Usage Guidelines section, unless there is sufficient documentation of efficacy and safety in the published literature.
  4. General Information:
    This field intentionally left blank.
  5. Therapeutic Alternatives:
    Drug Dosing Regimen Dose Limit/ Maximum Dose

    perindopril (Aceon)

    2 - 16 mg PO QD

    16 mg/day

    amlodipine (Norvasc)

    2.5 - 10 mg PO QD

    10 mg/day

    * Requires Prior Authorization
  6. Recommended Dosing Regimen and Authorization Limit:
    Drug Dosing Regimen Authorization Limit

    Prestalia

    3.5/2.5 mg perindopril/amlodipine PO QD, adjust dose every 1 to 2 weeks according to blood pressure goals

    Length of Benefit

  7. Product Availability:
    Tablet (perindopril/amlodipine): 3.5/2.5 mg, 7/5 mg, 14/10 mg
  8. References:
    1. Prestalia [Prescribing Information]. Cincinnati, OH: Symplmed; January 2015.
The material provided to you are guidelines used by this plan to authorize, modify or determine coverage for persons with similar illnesses or conditions. Specific care and treatment may vary depending on individual need and the benefits covered under your contract.